Avita Medical, INC Form 4 insider transactions

CFO David O'Toole acquired 2,000 shares of AVITA Medical common stock at a price of $3.97 per share.

Director Woody Fralin acquired 5,200 shares of AVITA Medical common stock in an open market transaction.

Director Woody Fralin purchased 10,000 shares of AVITA Medical common stock in open market transactions.

Director Woody Fralin purchased 10,000 shares of AVITA Medical common stock in two separate transactions on June 3, 2026.

Director Robert McNamara received restricted stock units and stock options following shareholder approval.

Director Woody Joseph Fralin reports the acquisition of restricted stock units and stock options following shareholder approval.

Director Michael Tarnoff disclosed the receipt of restricted stock units and stock options following shareholder approval.

AVITA Medical Director Jeremy Curnock Cook was granted 22,214 restricted stock units and 16,133 stock options, contingent on stockholder approval obtained on June 3, 2026.

Director Suzanne Crowe received an equity grant of restricted stock units and stock options following shareholder approval.

Director Jan Stern Reed received restricted stock units and stock options following shareholder approval.

AVITA Medical Director Joseph F. Woody acquired a total of 20,000 shares of common stock across multiple transactions on June 1st and 2nd, 2026.

AVITA Medical's CFO, David O'Toole, acquired 5,000 shares through the company's Employee Stock Purchase Plan.

AVITA Medical's President and CEO, Cary Guy Vance, acquired 5,000 shares of common stock through the company's Employee Share Purchase Plan.

AVITA Medical's CFO, David O'Toole, acquired 2,000 shares of common stock.

AVITA Medical's CFO, David D. O'Toole, filed a Form 4 indicating a pre-planned purchase of 3,000 shares of common stock set for February 19, 2026, at $4.15 per share under a Rule 10b5-1 plan.

AVITA Medical's CFO, David D. O'Toole, was granted 105,470 restricted stock units and 155,510 stock options as part of his compensation.

AVITA Medical's Chief Legal Officer, Nicole Kelsey, was granted 98,390 restricted stock units and 145,060 stock options as part of her compensation.

AVITA Medical Director Robert McNamara plans to acquire 10,000 shares of common stock at $4.50 per share, effective August 28, 2025, under a 10b5-1 plan.

AVITA Medical's CFO, David D. O'Toole, purchased 2,000 shares of common stock, signaling confidence in the company.

AVITA Medical Director Robert McNamara acquired 10,000 shares of common stock at $5 per share, increasing his direct beneficial ownership to 76,771 shares.

AVITA Medical's CFO, David D O'Toole, acquired 2,000 shares of common stock at $4.81 per share on August 12, 2025, increasing his beneficial ownership to 29,657 shares.

AVITA Medical, Inc. Director Cary Guy Vance was granted 10,022 Restricted Stock Units and 4,295 stock options, with these equity awards receiving stockholder approval on June 4, 2025.

AVITA Medical, Inc. Director Jan Stern Reed has reported the acquisition of 10,022 restricted stock units and 4,295 stock options as part of her compensation, following stockholder approval.

AVITA Medical, Inc. Director Robert McNamara has reported the acquisition of 10,022 restricted stock units and 4,295 stock options, aligning his interests with shareholders.

AVITA Medical, Inc. Director Jeremy Curnock Cook reported the acquisition of 10,022 restricted stock units and 4,295 stock options, granted on January 21, 2025, following stockholder approval on June 4, 2025.

AVITA Medical, Inc. Director Suzanne Crowe has reported the acquisition of 10,022 restricted stock units and 4,295 stock options, aligning her interests with the company's performance.

AVITA Medical, Inc. Director Lou Panaccio has reported the acquisition of 10,022 restricted stock units and 4,295 stock options as part of his compensation, following stockholder approval.

AVITA Medical, Inc. CEO and Director James Corbett was granted 520,000 stock options with an exercise price of $8.73, following shareholder approval on June 4, 2025.

AVITA Medical, Inc.'s Chief Financial Officer, David D. O'Toole, acquired 1,923 shares of common stock at a discounted price through the company's Employee Share Purchase Plan.

Director Robert McNamara of AVITA Medical, Inc. [RCEL] purchased 11,000 shares of common stock at $8.30 per share on March 6, 2025.